Treatment of Severe Heart Failure - AI: FineHeart Awarded €2.5 million Grant Under the Prestigious EIC Accelerator Program, the First Part of Blended Financing of up to €17.5 Million for the Development and Clinical Trials of the ICOMS FLOWMAKER

FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering

Related Keywords

France ,French ,Kostenloser Wertpapierhandel ,Annie Florence Loyer ,Arnaud Mascarell ,European Innovation Council ,European Union ,European Commission ,Implantable Cardiac Output Management System ,First In Human ,Horizon Europe ,Florence Loyer ,Treatment ,Evere ,Heart ,Failure ,Fineheart ,Warded ,Billion ,Rant ,Under ,Restigious ,Accelerator ,Program ,First ,Art ,Blended ,Financing ,Development ,Linical ,Trials ,Coms ,Lowmak ,